Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
Thorac Cancer. 2023 Apr;14(12):1089-1097. doi: 10.1111/1759-7714.14853. Epub 2023 Mar 16.
Thorac Cancer. 2023.
PMID: 36924358
Free PMC article.
Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis.
Xu S, Shukuya T, Tamura J, Shimamura S, Kurokawa K, Miura K, Miyawaki T, Hayakawa D, Asao T, Yamamoto K, Takahashi K.
Xu S, et al. Among authors: shimamura s.
JTO Clin Res Rep. 2022 Mar 19;3(4):100309. doi: 10.1016/j.jtocrr.2022.100309. eCollection 2022 Apr.
JTO Clin Res Rep. 2022.
PMID: 35434666
Free PMC article.
Item in Clipboard
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
Xu S, Miura K, Shukuya T, Harada S, Fujioka M, Winardi W, Shimamura S, Kurokawa K, Sumiyoshi I, Miyawaki T, Asao T, Mitsuishi Y, Tajima K, Takahashi F, Hayashi T, Harada N, Takahashi K.
Xu S, et al. Among authors: shimamura s.
Cancers (Basel). 2023 Feb 11;15(4):1170. doi: 10.3390/cancers15041170.
Cancers (Basel). 2023.
PMID: 36831513
Free PMC article.
Item in Clipboard
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
Shimamura SS, Shukuya T, Asao T, Hayakawa D, Kurokawa K, Xu S, Miura K, Mitsuishi Y, Tajima K, Shibayama R, Shimada N, Takahashi F, Takahashi K.
Shimamura SS, et al.
BMC Cancer. 2022 Mar 25;22(1):323. doi: 10.1186/s12885-022-09421-7.
BMC Cancer. 2022.
PMID: 35337281
Free PMC article.
Item in Clipboard
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report.
Xu S, Shukuya T, Shimamura S, Hayashi T, Sato Y, Shiozaki H, Nishioki T, Nishino K, Kato M, Hattori A, Shimada N, Suzuki K, Kitano S, Takahashi K.
Xu S, et al. Among authors: shimamura s.
Transl Lung Cancer Res. 2024 Mar 29;13(3):666-672. doi: 10.21037/tlcr-23-765. Epub 2024 Mar 27.
Transl Lung Cancer Res. 2024.
PMID: 38601437
Free PMC article.
Item in Clipboard
Cite
Cite